| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| A L McRae, K T Brad. Review of sertraline and its clinical applications in psychiatric disorders. Expert opinion on pharmacotherapy. vol 2. issue 5. 2002-09-19. PMID:11336629. |
sertraline (zoloft, pfizer) has been shown in numerous controlled studies to have similar efficacy to other selective serotonin (5-ht) re-uptake inhibitors (ssris) in the treatment of depression and anxiety disorders. |
2002-09-19 |
2023-08-12 |
Not clear |
| T Klaassen, W J Riedel, N E P Deutz, H M Van Praa. Mood congruent memory bias induced by tryptophan depletion. Psychological medicine. vol 32. issue 1. 2002-09-19. PMID:11885569. |
the influence of acute tryptophan (trp) depletion, inducing low serotonin neurotransmission and a depression of mood, on memory bias was evaluated in healthy volunteers (16 with and 11 without a family history of major affective disorder). |
2002-09-19 |
2023-08-12 |
human |
| Victoria Arango, Mark D Underwood, J John Man. Serotonin brain circuits involved in major depression and suicide. Progress in brain research. vol 136. 2002-09-19. PMID:12143401. |
serotonin brain circuits involved in major depression and suicide. |
2002-09-19 |
2023-08-12 |
Not clear |
| Victoria Arango, Mark D Underwood, J John Man. Serotonin brain circuits involved in major depression and suicide. Progress in brain research. vol 136. 2002-09-19. PMID:12143401. |
we examined whether prefrontal cortical (pfc) serotonin transporter sites (sert) differ in major depression and suicide by quantitative receptor autoradiography. |
2002-09-19 |
2023-08-12 |
Not clear |
| Vittorino Andreoli, Vincent Caillard, Ripu S Deo, Janusz K Rybakowski, Marcio Versian. Reboxetine, a new noradrenaline selective antidepressant, is at least as effective as fluoxetine in the treatment of depression. Journal of clinical psychopharmacology. vol 22. issue 4. 2002-09-18. PMID:12172339. |
the clinical profile of reboxetine, a selective noradrenaline reuptake inhibitor, was compared with that of the selective serotonin reuptake inhibitor fluoxetine and placebo in a double-blind, multicenter, parallel-group clinical trial of patients with major depression. |
2002-09-18 |
2023-08-12 |
Not clear |
| Brian J Jones, Thomas P Blackbur. The medical benefit of 5-HT research. Pharmacology, biochemistry, and behavior. vol 71. issue 4. 2002-09-11. PMID:11888547. |
the 5-ht reuptake inhibitors (ssris) are among the most widely prescribed drugs for treating depression and a variety of other disorders including anxiety, social phobia and premenstrual dysphoria (pmd). |
2002-09-11 |
2023-08-12 |
Not clear |
| Daniel Lin, Loren H Parson. Anxiogenic-like effect of serotonin(1B) receptor stimulation in the rat elevated plus-maze. Pharmacology, biochemistry, and behavior. vol 71. issue 4. 2002-09-11. PMID:11888549. |
perturbations in serotonin [5-hydroxytryptamine (5-ht)] neurotransmission have been implicated in several psychiatric illnesses including depression and anxiety disorders. |
2002-09-11 |
2023-08-12 |
rat |
| M I Smith, D C Piper, M S Duxon, N Upto. Effect of SB-243213, a selective 5-HT(2C) receptor antagonist, on the rat sleep profile: a comparison to paroxetine. Pharmacology, biochemistry, and behavior. vol 71. issue 4. 2002-09-11. PMID:11888551. |
it is evident that 5-ht(2) receptor function also plays an important role in depression. |
2002-09-11 |
2023-08-12 |
rat |
| Richard B Rothman, Michael H Bauman. Serotonin releasing agents. Neurochemical, therapeutic and adverse effects. Pharmacology, biochemistry, and behavior. vol 71. issue 4. 2002-09-11. PMID:11888573. |
in addition to the established indication of obesity, 5-ht releasers may be helpful in treating psychiatric problems such as drug and alcohol dependence, depression and premenstrual syndrome. |
2002-09-11 |
2023-08-12 |
Not clear |
| D Spinks, G Spink. Serotonin reuptake inhibition: an update on current research strategies. Current medicinal chemistry. vol 9. issue 8. 2002-09-11. PMID:11966445. |
selective serotonin reuptake inhibitors (ssris) have contributed to the major advances in the treatment of depression and other psychiatric diseases. |
2002-09-11 |
2023-08-12 |
Not clear |
| D Spinks, G Spink. Serotonin reuptake inhibition: an update on current research strategies. Current medicinal chemistry. vol 9. issue 8. 2002-09-11. PMID:11966445. |
this area of research has shed light on the pharmacological mechanisms of ssri therapy and has the therapeutic usefulness of serotonin reuptake inhibition, especially in the area of depression. |
2002-09-11 |
2023-08-12 |
Not clear |
| A Wade, O Michael Lemming, K Bang Hedegaar. Escitalopram 10 mg/day is effective and well tolerated in a placebo-controlled study in depression in primary care. International clinical psychopharmacology. vol 17. issue 3. 2002-09-06. PMID:11981349. |
escitalopram, a selective serotonin reuptake inhibitor (ssri), was compared to placebo in a study of patients with major depressive disorder (dsm-iv) who had baseline montgomery-asberg depression rating scale (madrs) total scores >or=22 and
| 2002-09-06 |
2023-08-12 |
Not clear |
|
| M Kimura, K Kanetani, R Imai, H Suzuki, K Isayama, S End. Therapeutic effects of milnacipran, a serotonin and noradrenaline reuptake inhibitor, on post-stroke depression. International clinical psychopharmacology. vol 17. issue 3. 2002-09-06. PMID:11981353. |
therapeutic effects of milnacipran, a serotonin and noradrenaline reuptake inhibitor, on post-stroke depression. |
2002-09-06 |
2023-08-12 |
Not clear |
| M Kimura, K Kanetani, R Imai, H Suzuki, K Isayama, S End. Therapeutic effects of milnacipran, a serotonin and noradrenaline reuptake inhibitor, on post-stroke depression. International clinical psychopharmacology. vol 17. issue 3. 2002-09-06. PMID:11981353. |
while several reports have been published on the use of antidepressants such as selective serotonin reuptake inhibitors and tricyclics for the treatment of post-stroke depression (psd), no previous study has examined the use of a selective serotonin and noradrenaline reuptake inhibitor (snri) for this condition. |
2002-09-06 |
2023-08-12 |
Not clear |
| B Bandelo. [Behavior therapy and antidepressive drugs. What helps with anxiety?]. MMW Fortschritte der Medizin. vol Suppl 2. 2002-09-03. PMID:12070854. |
selective serotonin reuptake inhibitors are the medication of first choice in anxiety disorders and comorbid depression. |
2002-09-03 |
2023-08-12 |
Not clear |
| Martyn D Wood, David R Thomas, Jeannette M Watso. Therapeutic potential of serotonin antagonists in depressive disorders. Expert opinion on investigational drugs. vol 11. issue 4. 2002-08-15. PMID:11922855. |
although the precise neurochemical imbalances in depression are still unknown, a role for the neurotransmitter 5-hydroxytryptamine (serotonin) has been implicated since the identification of the first effective antidepressants, imipramine and iproniazid. |
2002-08-15 |
2023-08-12 |
rat |
| Martyn D Wood, David R Thomas, Jeannette M Watso. Therapeutic potential of serotonin antagonists in depressive disorders. Expert opinion on investigational drugs. vol 11. issue 4. 2002-08-15. PMID:11922855. |
this led to the development of the selective serotonin re-uptake inhibitors which are widely used in the treatment of depression and depressive disorders, including generalised anxiety disorder, social phobia, obsessive compulsive disorder etc. |
2002-08-15 |
2023-08-12 |
rat |
| V E Golimbet, M V Alfimova, T V Shcherbatykh, E I Rogae. [Allele polymorphism of the serotonin transporter gene and clinical heterogeneity of depressive disorders]. Genetika. vol 38. issue 5. 2002-08-13. PMID:12068552. |
allele polymorphism of the serotonin transporter (5-htt) gene was tested for association with age at disease onset, clinical signs, and anxiety-related traits of depression patients. |
2002-08-13 |
2023-08-12 |
Not clear |
| L Labat, M Deveaux, P Dallet, J P Dubos. Separation of new antidepressants and their metabolites by micellar electrokinetic capillary chromatography. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences. vol 773. issue 1. 2002-08-06. PMID:12015266. |
selective serotonin reuptake inhibitors (ssris), serotonin noradrenergic reuptake inhibitors (snaris) and noradrenergic and specific serotoninergic antidepressant (nassa) are widely used in the treatment of depression. |
2002-08-06 |
2023-08-12 |
Not clear |
| Alexander Neumeister, Anastasios Konstantinidis, Juergen Stastny, Markus J Schwarz, Oliver Vitouch, Matthaus Willeit, Nicole Praschak-Rieder, Johanna Zach, Martina de Zwaan, Brigitta Bondy, Manfred Ackenheil, Siegfried Kaspe. Association between serotonin transporter gene promoter polymorphism (5HTTLPR) and behavioral responses to tryptophan depletion in healthy women with and without family history of depression. Archives of general psychiatry. vol 59. issue 7. 2002-08-06. PMID:12090814. |
association between serotonin transporter gene promoter polymorphism (5httlpr) and behavioral responses to tryptophan depletion in healthy women with and without family history of depression. |
2002-08-06 |
2023-08-12 |
human |